Thomas Hedner and Jean Lycke (2019) “CRISPR/Cas9 system and gene editing tools: On patent rights, recent disputes and its potential commercial applicability in biotechnology and medicine”, Stockholm Intellectual Property Law Review , 2(1), pp. 12–23. doi: 10.59625/siplr.v2i1.63298.